Effects of Inspiratory Muscle Training After Lung Cancer Surgery, a Randomized Controlled Trial

January 19, 2015 updated by: Barbara C. Brocki, Aalborg University Hospital

Respiratory Muscle Strength, Functional Capacity and Subjective Outcome - Effects of Inspiratory Muscle Training After Lung Cancer Surgery, a Randomized Controlled Trial

The purpose of this study is to evaluate the effects of postoperative inspiratory muscle training on the recovery of respiratory muscle strength in high risk patients referred for lung cancer surgery. Furthermore, to assess longitudinal changes in respiratory muscle strength, physical capacity and health-related quality of life after lung cancer surgery

Study Overview

Detailed Description

Advances in early detection and treatment improve life expectancy after surgery for lung cancer, but living with lung cancer is frequently associated with symptoms as dyspnoea, decreased physical capacity and fatigue several years after treatment. Lung cancer (LC) surgery is associated with a high incidence of postoperative pulmonary complications (PPC), having a negative impact on recovery. Although the causes of PPC are multifactorial, respiratory muscle (RM) dysfunction has been proposed to be associated with the development of PPC, explained by changes in RM mechanics- and function due to surgery. There is scarcity of literature on the impact of RM dysfunction on surgical and functional outcomes after LC surgery.

Aims: to describe longitudinal changes in RM strength in patients undergoing lung cancer surgery and identify associations between RM strength and functional capacity. Furthermore, to evaluate the effect of inspiratory muscle training on the recovery of respiratory muscle strength in high risk patients referred for LC surgery.

Target population: 88 patients referred for lung cancer surgery at the Department of Cardiothoracic Surgery, Aalborg Universityhospital.

Design: The core of this research is a prospective longitudinal observational study (study 1); included is a randomized controlled trial, based on a subpopulation from study 1.

Statistical analysis is based on mixed linear regression models and ANOVA. For the RCT we use the generalized estimating equivalent method for parametric and Fisher´s exact test for nonparametric data.

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aalborg, Denmark, 9100
        • Department of Cardiothoracic Surgery, Aalborg Universityhospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age >18 years; scheduled for thoracic surgery on the suspicion/confirmed lung tumor via open thoracotomy or Visual Assisted Thoracotomy(includes primary lung cancer, metastases from other cancer sites without activity within none year, other tumor types requiring resection of lung tissue; Furthermore, for RCT, one of the following: Age ≥ 70 years or FEV1 ≤ 70% predicted or DLCO ≤ 70% predicted or scheduled pneumonectomy)

Exclusion Criteria:

  • physical or mental deficits that adversely influence physical performance; can neither speak nor read Danish; previous ipsilateral lung resection; tumor activity in other sites or organs; pancoast tumor

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Inspiratory muscle training
Inspiratory muscle training for two weeks following surgery
Inspiratory muscle training, as a supplement to placebo comparator, starts the day before surgery and continues for two weeks after surgery. No sessions are performed on the surgery day. Each session consists of 2 sets of 30 inspirations with a pause between each set of 2 minutes. The target intensity before surgery is 30% of the measured MIP and starts at 15% after surgery. The intensity is incrementally increased by 2 cm H20 the first days after surgery. Patients grade their perceived exertion and register eventual adverse effects in a training diary.
Other Names:
  • IMT
Standard physiotherapy - preoperative instruction and postoperative breathing exercises using positive expiratory pressure device (PEP) 3x10 breathings hourly during daytime, cough/huff for mucus clearance purpose, advice on early and active mobilization
Placebo Comparator: Standard physiotherapy
Breathing exercises, cough/hugh, advice on early and active mobilization
Standard physiotherapy - preoperative instruction and postoperative breathing exercises using positive expiratory pressure device (PEP) 3x10 breathings hourly during daytime, cough/huff for mucus clearance purpose, advice on early and active mobilization

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in inspiratory muscle strength
Time Frame: Before surgery, 5.postoperative day, 2 weeks after surgery
Change from baseline to 5th postoperative day Change from baseline to 2 weeks after surgery
Before surgery, 5.postoperative day, 2 weeks after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in expiratory muscle strength
Time Frame: Before surgery, 5 th postoperative day and 2 weeks after surgery
Change from baseline to 5th postoperative day Change from baseline to 2 weeks after surgery
Before surgery, 5 th postoperative day and 2 weeks after surgery
Incidence of postoperative pulmonary complications
Time Frame: 2 weeks after surgery
2 weeks after surgery

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in walking distance, 6 minute
Time Frame: before surgery, 5th postoperative day and 2 weeks after surgery
Change from baseline to 5th postoperative day Change from baseline to 2 weeks after surgery
before surgery, 5th postoperative day and 2 weeks after surgery
Change in spirometry values(FVC, FEV1)
Time Frame: before surgery, 5th day, 2 weeks after surgery
Change from baseline to 5th postoperative day Change from baseline to 2 weeks after surgery
before surgery, 5th day, 2 weeks after surgery
Change in Borg CR-10 dyspnea
Time Frame: Before surgery, 5th postoperative day and 2 weeks after surgery
Change from baseline to 5th postoperative day Change from baseline to 2 weeks after surgery
Before surgery, 5th postoperative day and 2 weeks after surgery
Change in EORTC QLQ-C30-LC13
Time Frame: Before surgery and 2 weeks after surgery
Before surgery and 2 weeks after surgery
Change in EQ-5D-5L
Time Frame: Before surgery and 2 weeks after surgery
Before surgery and 2 weeks after surgery
Change in Physical Activity Score- PAS
Time Frame: Before surgery and 2 weeks after surgery
Before surgery and 2 weeks after surgery
Change in numeric rang score for pain
Time Frame: Before surgery, 5th postoperative day and 2 weeks after surgery
Change from baseline to 5th postoperative day Change from baseline to 2 weeks after surgery
Before surgery, 5th postoperative day and 2 weeks after surgery
Change in numeric rang score for cough efficiency
Time Frame: 5th postoperative day and 2 weeks after surgery
5th postoperative day and 2 weeks after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Barbara C Brocki, PT, Department of Occupational Therapy- and Physiotherapy, Aalborg Universityhospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2012

Primary Completion (Actual)

April 1, 2014

Study Completion (Actual)

December 1, 2014

Study Registration Dates

First Submitted

February 13, 2013

First Submitted That Met QC Criteria

February 14, 2013

First Posted (Estimate)

February 15, 2013

Study Record Updates

Last Update Posted (Estimate)

January 21, 2015

Last Update Submitted That Met QC Criteria

January 19, 2015

Last Verified

January 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lung Cancer

Clinical Trials on Inspiratory muscle training

3
Subscribe